Home » ocular pressure trial

Iris Pharma is the first worldwide contract research organization (CRO) dedicated to ophthalmology and specializing in carrying out Eye Clinical Trials (Phase I, Phase II, Phase III and Phase IV).

Iris Pharma performs clinical trials (Ocular Pressure Trials, Ocular Neovascularizzation Trialsetc.) throughout Europe, North Africa, India, South Arabia and North America.

Iris Pharma has the following fields of expertise :

• Glaucoma and Ocular Pressure Trial
• Dry eye syndrome
• Cataract
• Ocular inflammation
• Ocular allergy

About Iris Pharma's Ocular Pressure Trial

Iris Pharma of France, a specialist contract research organization (CRO) for pre-clinical research in ophthalmology, has announced the completion of its merger with Clirophtha, a unique CRO in Europe and North America that is completely dedicated to ophthalmology clinical trials such as the Ocular Pressure Trial.

Over the last 13 years, Clirophtha has managed more than 76 clinical trials in ophthalmology in 14500 subjects and specifically for the ocular pressure trial a number of 27 clinical studies for 3 800 patients.

With the merger, Iris Pharma offers partial or full-service phase I-IV clinical studies (ocular pressure trial, ocular neovascularization studies, ocular drug development, ocular allergy.) monitoring and project management depending on your specific requirements but also preclinical research.